On the public citation graph

Identification of New N-methyl-piperazine Chalcones as Dual MAO-B/AChE Inhibitors

0 signed · 77 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/ardp.201300242openalex-snapshot

Design, Synthesis, Biological Evaluation, and Molecular Modeling of Coumarin– P iperazine Derivatives as Acetylcholinesterase Inhibitors

inferredcites →https://doi.org/10.1002/cmdc.201600497openalex-snapshot

Monoamine Oxidase Inhibitory Activity: Methyl‐ versus Chlorochalcone Derivatives

inferredcites →https://doi.org/10.1002/cmdc.202000491openalex-snapshot

Selected 1,3‐Benzodioxine‐Containing Chalcones as Multipotent Oxidase and Acetylcholinesterase Inhibitors

inferredcites →https://doi.org/10.1002/ejoc.201201122openalex-snapshot

How are Biogenic Amines Metabolized by Monoamine Oxidases?

inferredcites →https://doi.org/10.1002/jcc.21287openalex-snapshot

CHARMM: The biomolecular simulation program

inferredcites →https://doi.org/10.1002/jcc.21334openalex-snapshot

AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

inferredcites →https://doi.org/10.1002/jhet.4156openalex-snapshot

Phenothiazine‐based chalcones as potential dual‐target inhibitors toward cholinesterases (AChE, BuChE) and monoamine oxidases (MAO‐A, MAO‐B)

inferredcites →https://doi.org/10.1002/slct.201901093openalex-snapshot

Ethoxylated Head of Chalcones as a New Class of Multi‐Targeted MAO Inhibitors

inferredcites →https://doi.org/10.1007/s11356-021-13320-yopenalex-snapshot

Piperazine-substituted chalcones: a new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disorders

inferredcites →https://doi.org/10.1016/0006-2952(61)90145-9openalex-snapshot

A new and rapid colorimetric determination of acetylcholinesterase activity

inferredcites →https://doi.org/10.1016/j.bioorg.2018.01.020openalex-snapshot

Synthesis, biological evaluation and molecular modeling studies of phenyl-/benzhydrylpiperazine derivatives as potential MAO inhibitors

inferredcites →https://doi.org/10.1016/j.bioorg.2019.103335openalex-snapshot

Design, synthesis and biological evaluation of oxygenated chalcones as potent and selective MAO-B inhibitors

inferredcites →https://doi.org/10.1016/j.bioorg.2019.103477openalex-snapshot

Flurbiprofen-chalcone hybrid Mannich base derivatives as balanced multifunctional agents against Alzheimer’s disease: Design, synthesis and biological evaluation

inferredcites →https://doi.org/10.1016/j.bioorg.2022.106007openalex-snapshot

Novel donepezil-chalcone-rivastigmine hybrids as potential multifunctional anti-Alzheimer's agents: Design, synthesis, in vitro biological evaluation, in vivo and in silico studies

inferredcites →https://doi.org/10.1016/j.bmc.2016.12.013openalex-snapshot

Design, synthesis and biological evaluation of 4′-aminochalcone-rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer's disease

inferredcites →https://doi.org/10.1016/j.bmcl.2016.08.044openalex-snapshot

Potent selective monoamine oxidase B inhibition by maackiain, a pterocarpan from the roots of Sophora flavescens

inferredcites →https://doi.org/10.1016/j.ddtec.2004.11.007openalex-snapshot

Lead- and drug-like compounds: the rule-of-five revolution

inferredcites →https://doi.org/10.1016/j.ejmech.2011.02.071openalex-snapshot

Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer’s disease

inferredcites →https://doi.org/10.1016/j.ejmech.2016.02.038openalex-snapshot

Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors

inferredcites →https://doi.org/10.1016/j.ejmech.2018.07.056openalex-snapshot

Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors

inferredcites →https://doi.org/10.1016/j.ejmech.2019.05.020openalex-snapshot

Multi-target design strategies for the improved treatment of Alzheimer's disease

inferredcites →https://doi.org/10.1016/j.ejmech.2019.07.040openalex-snapshot

Multi-target-directed-ligands acting as enzyme inhibitors and receptor ligands

inferredcites →https://doi.org/10.1016/j.ejmech.2020.112650openalex-snapshot

Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors

inferredcites →https://doi.org/10.1016/j.ejmech.2021.113310openalex-snapshot

Design, synthesis and evaluation of novel dimethylamino chalcone-O-alkylamines derivatives as potential multifunctional agents against Alzheimer’s disease

inferredcites →https://doi.org/10.1016/j.ijbiomac.2020.02.144openalex-snapshot

Calycosin and 8-O-methylretusin isolated from Maackia amurensis as potent and selective reversible inhibitors of human monoamine oxidase-B

inferredcites →https://doi.org/10.1016/s1474-4422(18)30295-3openalex-snapshot

Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

inferredcites →https://doi.org/10.1021/acs.chemrev.7b00020openalex-snapshot

Chalcone: A Privileged Structure in Medicinal Chemistry

inferredcites →https://doi.org/10.1021/acs.jmedchem.0c01775openalex-snapshot

Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice

inferredcites →https://doi.org/10.1021/acs.jmedchem.1c00963openalex-snapshot

Small Molecule Kinase Inhibitor Drugs (1995–2021): Medical Indication, Pharmacology, and Synthesis

inferredcites →https://doi.org/10.1021/acs.jmedchem.1c01784openalex-snapshot

Probing Fluorinated Motifs onto Dual AChE-MAO B Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Early-ADME Studies

inferredcites →https://doi.org/10.1021/jm300978hopenalex-snapshot

Multitarget-Directed Benzylideneindanone Derivatives: Anti-β-Amyloid (Aβ) Aggregation, Antioxidant, Metal Chelation, and Monoamine Oxidase B (MAO-B) Inhibition Properties against Alzheimer’s Disease

inferredcites →https://doi.org/10.1021/jm801590uopenalex-snapshot

Chalcones: A Valid Scaffold for Monoamine Oxidases Inhibitors

inferredcites →https://doi.org/10.1038/nprot.2016.051openalex-snapshot

Computational protein–ligand docking and virtual drug screening with the AutoDock suite

inferredcites →https://doi.org/10.1038/srep42717openalex-snapshot

SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules

inferredcites →https://doi.org/10.1073/pnas.0710626105openalex-snapshot

Structure of human monoamine oxidase A at 2.2-Å resolution: The control of opening the entry for substrates/inhibitors

inferredcites →https://doi.org/10.1073/pnas.102179699openalex-snapshot

Evaluating conformational free energies: The colony energy and its application to the problem of loop prediction

inferredcites →https://doi.org/10.1080/13543776.2016.1189902openalex-snapshot

Piperazine derivatives for therapeutic use: a patent review (2010-present)

inferredcites →https://doi.org/10.1080/14756366.2020.1842390openalex-snapshot

Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations

inferredcites →https://doi.org/10.1111/fcp.12408openalex-snapshot

Piperazine derivatives with central pharmacological activity used as therapeutic tools

inferredcites →https://doi.org/10.1126/sciadv.aav0316openalex-snapshot

Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer’s disease

inferredcites →https://doi.org/10.1212/wnl.47.6_suppl_3.161sopenalex-snapshot

Oxidative stress and the pathogenesis of Parkinson's disease

inferredcites →https://doi.org/10.1517/13543776.2012.698613openalex-snapshot

Patent-related survey on new monoamine oxidase inhibitors and their therapeutic potential

inferredcites →https://doi.org/10.2147/ppa.s11182openalex-snapshot

Efficacy, safety, and patient preference of monoamine oxidase B inhibitors in the treatment of Parkinson's disease

inferredcites →https://doi.org/10.2174/0929867325666180111101843openalex-snapshot

Multi-Target Directed Drugs as a Modern Approach for Drug Design Towards Alzheimer’s Disease: An Update

inferredcites →https://doi.org/10.2174/1386207323666200428091306openalex-snapshot

A Comprehensive Review of Monoamine Oxidase-A Inhibitors in their Syntheses and Potencies

inferredcites →https://doi.org/10.2174/1568026621999210902123132openalex-snapshot

Recent Updates on Pyrazoline Derivatives as Promising Candidates for Neuropsychiatric and Neurodegenerative Disorders

inferredcites →https://doi.org/10.3390/ijms20030719openalex-snapshot

Novel Approaches for the Treatment of Alzheimer’s and Parkinson’s Disease

inferredcites →https://doi.org/10.3390/molecules25214941openalex-snapshot

Newly Synthesized Fluorinated Cinnamylpiperazines Possessing Low In Vitro MAO-B Binding

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.3897/pharmacia.72.e164727zenodo-depositor-declared

Multi-target monoamine oxidase-B (MAO-B) inhibitors in the treatment of Parkinson’s disease

inferred← citeshttps://doi.org/10.1002/ardp.70046openalex-snapshot

Click Chemistry‐Aided Synthesis of Triazole‐Tethered Benzothiazoles as Novel Multifunctional Agents Against Alzheimer's Disease

inferred← citeshttps://doi.org/10.1002/ddr.70349openalex-snapshot

Discovery of a Potent and Selective MAO‐B Inhibitor From a Donepezil‐Linked Chalcone Library With Promising Antiparkinsonian Activity

inferred← citeshttps://doi.org/10.1002/slct.202400465openalex-snapshot

Chalcones with N‐Methylpiperazine Moiety: Synthesis, Monoamine Oxidase Inhibition, Neuroprotective Effect and Computer Simulation Study

inferred← citeshttps://doi.org/10.1002/slct.202404717openalex-snapshot

Inhibitory Activity of Chalcones as MAO‐B Inhibitors: An Insight from Molecular Docking, ADME Analysis, MD Simulation, and MM‐PBSA Calculations

inferred← citeshttps://doi.org/10.1007/s00894-024-05889-1openalex-snapshot

Probing the inhibition of MAO-B by chalcones: an integrated approach combining molecular docking, ADME analysis, MD simulation, and MM-PBSA calculations

inferred← citeshttps://doi.org/10.1007/s11030-024-10841-9openalex-snapshot

Rational design, synthesis, biological evaluation, and molecular modeling of novel naphthamide derivatives possessing potent, reversible, and competitive inhibitory mode of action over human monoamine oxidase

inferred← citeshttps://doi.org/10.1007/s11030-024-10959-wopenalex-snapshot

Inhibition of monoamine oxidases and neuroprotective effects: chalcones vs. chromones

inferred← citeshttps://doi.org/10.1007/s11030-026-11733-wopenalex-snapshot

Discovery of potent and selective MAO-B inhibitors from a morpholine-substituted chalcone library for neurodegenerative disorders

inferred← citeshttps://doi.org/10.1007/s11696-026-04818-1openalex-snapshot

Piperazine as a privileged scaffold in medicinal chemistry: biological activities, synthetic strategies, and multitarget drug design

inferred← citeshttps://doi.org/10.1016/b978-0-443-43812-7.00001-0openalex-snapshot

Chalcones as neuroprotective and anti-Alzheimer’s disease agents

inferred← citeshttps://doi.org/10.1016/b978-0-443-43812-7.00011-3openalex-snapshot

Pharmacokinetic properties, pharmacomicrobiomics, and bioavailability of natural and synthetic chalcones

inferred← citeshttps://doi.org/10.1016/j.bioorg.2023.106939openalex-snapshot

Novel coumarin benzamides as potent and reversible monoamine oxidase-B inhibitors: Design, synthesis, and neuroprotective effects

inferred← citeshttps://doi.org/10.1016/j.bioorg.2026.110013openalex-snapshot

Identification of a nanomolar, selective MAO-B inhibitor from piperidine-based chalcones with anti-Parkinson potential

inferred← citeshttps://doi.org/10.1016/j.bmcl.2026.130716openalex-snapshot

Rational design, synthesis, and biological evaluation of chalcone hybrids including benzoylpiperazin (phenylacetylpiperazin)-thiophene as anti- Alzheimer's agents

inferred← citeshttps://doi.org/10.1016/j.ejmech.2024.116810openalex-snapshot

Dual-target inhibitors based on acetylcholinesterase: Novel agents for Alzheimer's disease

inferred← citeshttps://doi.org/10.1016/j.lfs.2023.121568openalex-snapshot

An ongoing journey of chalcone analogues as single and multi-target ligands in the field of Alzheimer's disease: A review with structural aspects

inferred← citeshttps://doi.org/10.1016/j.molstruc.2024.140503openalex-snapshot

Isatin derived morpholine and piperazine derivatives as acetylcholinesterase inhibitors

inferred← citeshttps://doi.org/10.1016/j.molstruc.2026.147033openalex-snapshot

Synthesis, spectroscopic characterizations and structural analysis of (E)-1-(4-(4-(2-hydroxyethyl)piperazin-1-yl)phenyl)-3-phenylprop-2-en-1-one

inferred← citeshttps://doi.org/10.1016/j.tet.2025.134978openalex-snapshot

Novel piperazine derivatives as MAO-B inhibitors: Design, synthesis and computational exploration through molecular docking, MD simulations, MM-PBSA and DFT studies

inferred← citeshttps://doi.org/10.1021/acsinfecdis.5c00564openalex-snapshot

Synthesis of Innovative Photosensitizers for Enhanced Photodynamic Therapy of Drug-Resistant Pathogens and Biofilms

inferred← citeshttps://doi.org/10.1039/d5ra06971hopenalex-snapshot

Inhibition of monoamine oxidase by fluorobenzyloxy chalcone derivatives

inferred← citeshttps://doi.org/10.1039/d6ra05787jopenalex-snapshot

Discovery of tricyclic benzo[4,5]imidazo[2,1- b ]thiazole-3-hydroxyindolin-2-one hybrids as selective MAO-B and cholinesterase inhibitors

inferred← citeshttps://doi.org/10.1080/10286020.2026.2693149openalex-snapshot

Study on structural modification and hepatoprotective activities of shikonofuran derivatives

inferred← citeshttps://doi.org/10.2174/0115701786403432260129211331openalex-snapshot

Advances in Synthesis of Piperazine Analogues and Molecular Targets: Unlocking Their Potential in CNS Disorder Therapy

inferred← citeshttps://doi.org/10.3390/ijms24098164openalex-snapshot

β-Secretase-1: In Silico Drug Reposition for Alzheimer’s Disease

inferred← citeshttps://doi.org/10.3390/ijms24119482openalex-snapshot

Towards Novel Potential Molecular Targets for Antidepressant and Antipsychotic Pharmacotherapies

inferred← citeshttps://doi.org/10.52711/0974-360x.2025.00589openalex-snapshot

Unveiling Pyridocarbazole Fused with Carbamate as MAO-B Inhibitors using In silico and In vitro approaches

inferred← citeshttps://doi.org/10.55971/ejls.1497639openalex-snapshot

Investigation of dual AChE/MAO inhibitory activities of new morpholine and piperazine structured compounds

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.